Search Within

Yongxing Gong

Formats
  1. Journal Article (10)
Groups
  1. GSK Faculty (10)
  2. Sloan Kettering Institute Postdocs (10)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (9)
  4. Surgery (7)
  5. Department of Pathology and Laboratory Medicine (6)
  6. Human Oncology and Pathogenesis Program (6)

More Groups

People
  1. Timothy Chan (9)
  2. Ian Ganly (5)
  3. Luc Morris (5)
  4. Agnes Viale (3)
  5. Bhuvanesh Singh (3)
  6. Sevin Turcan (3)

More People

Years
  1. 2022 (2)
  2. 2020 (1)
  3. 2017 (1)
  4. 2014 (2)
  5. 2013 (2)
  6. 2011 (1)

More Years

Publications
  1. Nature Genetics (3)
  2. Science Advances (2)
  3. Cell Cycle (1)
  4. Molecular Cancer Therapeutics (1)
  5. NeoPlasia (1)
  6. Oncogene (1)

More Publications

Publishers
  1. Nature Publishing Group (4)
  2. Amer Assoc Advancement Science (2)
  3. American Association for Cancer Research (1)
  4. Elsevier Science Inc. (1)
  5. National Academy of Sciences (1)
  6. Taylor & Francis Inc. (1)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma
    Journal Article

    Ganly, I.; Liu, E. M.; Kuo, F.; Makarov, V.; Dong, Y.; Park, J.; Gong, Y.; Gorelick, A. N.; Knauf, J. A.; Benedetti, E.; more...
    Science Advances (2022)

    Fulltext@MSK | Save
  • Targeting the mTOR pathway in hurthle cell carcinoma results in potent antitumor activity
    Journal Article

    Dong, Y.; Gong, Y.; Kuo, F.; Makarov, V.; Reznik, E.; Nanjangud, G. J.; Aras, O.; Zhao, H.; Qu, R.; Fagin, J. A.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas
    Journal Article

    Wang, Y.; Wild, A. T.; Turcan, S.; Wu, W. H.; Sigel, C.; Klimstra, D. S.; Ma, X.; Gong, Y.; Holland, E. C.; Huse, J. T.; more...
    Science Advances (2020)

    Fulltext@MSK | Save
  • Pan-cancer analysis links PARK2 to BCL-XL-dependent control of apoptosis
    Journal Article

    Gong, Y.; Schumacher, S. E.; Wu, W. H.; Tang, F.; Beroukhim, R.; Chan, T. A.
    NeoPlasia (2017)

    Fulltext@MSK | Save
  • Molecular mechanisms orchestrating cyclin stability
    Journal Article

    Gong, Y.; Chan, T. A.
    Cell Cycle (2014)

    Fulltext@MSK | Save
  • Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins
    Journal Article

    Gong, Y.; Zack, T. I.; Morris, L. G. T.; Lin, K.; Hukkelhoven, E.; Raheja, R.; Tan, I. L.; Turcan, S.; Veeriah, S.; Meng, S.; more...
    Nature Genetics (2014)

    Fulltext@MSK | Save
  • The mutational landscape of adenoid cystic carcinoma
    Journal Article

    Ho, A. S.; Kannan, K.; Roy, D. M.; Morris, L. G. T.; Ganly, I.; Katabi, N.; Ramaswami, D.; Walsh, L. A.; Eng, S.; Huse, J. T.; more...
    Nature Genetics (2013)

    Fulltext@MSK | Save
  • Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation
    Journal Article

    Morris, L. G. T.; Kaufman, A. M.; Gong, Y.; Ramaswami, D.; Walsh, L. A.; Turcan, S.; Eng, S.; Kannan, K.; Zou, Y.; Peng, L.; more...
    Nature Genetics (2013)

    Fulltext@MSK | Save
  • Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers
    Journal Article

    Morris, L. G. T.; Taylor, B. S.; Bivona, T. G.; Gong, Y.; Eng, S.; Brennan, C. W.; Kaufman, A.; Kastenhuber, E. R.; Banuchi, V. E.; Singh, B.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2011)

    Fulltext@MSK | Save
  • An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors
    Journal Article

    Chitale, D.; Gong, Y.; Taylor, B. S.; Broderick, S.; Brennan, C.; Somwar, R.; Golas, B.; Wang, L.; Motoi, N.; Szoke, J.; more...
    Oncogene (2009)

    Fulltext@MSK | Save